These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 8739510

  • 1. Pharmacokinetics of topically applied ciprofloxacin in rabbit tears.
    Green LC, Callegan MC, Engel LS, Shimomura Y, Jasheway DW, O'Callaghan RJ, Hill JM.
    Jpn J Ophthalmol; 1996; 40(1):123-6. PubMed ID: 8739510
    [Abstract] [Full Text] [Related]

  • 2. Comparative tear concentrations of topically applied ciprofloxacin, ofloxacin, and norfloxacin in human eyes.
    Akkan AG, Mutlu I, Ozyazgan S, Gök A, Yigit U, Ozüner Z, Senses V, Pekel H.
    Int J Clin Pharmacol Ther; 1997 May; 35(5):214-7. PubMed ID: 9174877
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics of topically applied ciprofloxacin in equine tears.
    Hendrix DV, Stuffle JL, Cox SK.
    Vet Ophthalmol; 2007 May; 10(6):344-7. PubMed ID: 17970994
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Tear concentrations of topically applied ciprofloxacin.
    Limberg M, Buggé C.
    Cornea; 1994 Nov; 13(6):496-9. PubMed ID: 7842707
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. An in vivo study comparing the ocular absorption of levofloxacin and ciprofloxacin prior to phacoemulsification.
    Bucci FA.
    Am J Ophthalmol; 2004 Feb; 137(2):308-12. PubMed ID: 14962422
    [Abstract] [Full Text] [Related]

  • 11. Penetration of ciprofloxacin, norfloxacin and ofloxacin into the aqueous humours of patients by different topical application modes.
    von Keyserlingk J, Beck R, Fischer U, Hehl EM, Guthoff R, Drewelow B.
    Eur J Clin Pharmacol; 1997 Feb; 53(3-4):251-5. PubMed ID: 9476040
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Role of topical fluoroquinolones on the pathogenesis of diffuse lamellar keratitis in experimental in vivo studies.
    Mah FS, Romanowski EG, Dhaliwal DK, Yates KA, Gordon YJ.
    J Cataract Refract Surg; 2006 Feb; 32(2):264-8. PubMed ID: 16565003
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Topical 0.3% ciprofloxacin, norfloxacin, and ofloxacin in treatment of bacterial keratitis: a new method for comparative evaluation of ocular drug penetration.
    Diamond JP, White L, Leeming JP, Bing Hoh H, Easty DL.
    Br J Ophthalmol; 1995 Jun; 79(6):606-9. PubMed ID: 7626579
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.